Skip to main
NHP

NHP Stock Forecast & Price Target

NHP Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

National Healthcare is expected to experience growth in the near term due to their unique focus on acquiring seniors housing communities in middle markets with higher yields and less competition. However, there is a risk of management turnover and potential impact from weather-related damages and climate change. The company's transition towards a SHOP portfolio and plans to increase dividends annually from the third quarter of 2026 show a strong leadership team and favorable operator relationships. Additionally, the improvement in the debt and leverage profile, as well as the predicted increase in FFO and FAD per share, suggest positive fundamentals and potential for long-term growth.

Bears say

National Healthcare is a publicly registered real estate investment trust that operates in the healthcare real estate sector with a focus on senior housing and outpatient medical facilities. The negative outlook on the company is primarily driven by potential risks to the company's earnings and valuation, including general market conditions, consumer preferences, and regulatory trends. Additionally, the company's high leverage and concentration in certain geographic regions pose risks to its financial performance. The recent shift in the company's portfolio mix also adds uncertainty to its future earnings and dividend growth potential.

NHP has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Healthcare Properties and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Healthcare Properties (NHP) Forecast

Analysts have given NHP a Buy based on their latest research and market trends.

According to 7 analysts, NHP has a Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Healthcare Properties (NHP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.